Navigation Links
Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/11/2011

ients greater precision in their efforts to fine tune their glucose control. Patients treated with insulin pumps represent a significant portion of the market, manage their disease aggressively, and are early adopters of new treatments and technologies.
  • Halozyme's two Phase 2 clinical studies that compare treatment with an insulin analog alone to Analog-PH20 for twelve weeks each completed patient enrollment this past January. Results from these two studies will be available to Halozyme internally during the third quarter of 2011.
  • Roche completed patient enrollment of its Phase 3 registration study for Herceptin® SC (trastuzumab subcutaneous) in December for the treatment of HER2-positive breast cancer and has stated it expects to have results from this study by the end of 2011. In February 2011, Roche began patient dosing of the Phase 3 MabThera® SC (rituximab subcutaneous) clinical trial in patients with follicular non-Hodgkin's lymphoma. Roche has stated it expects to file for the approval of Herceptin SC and MabThera SC in the EU during 2012.
  • Baxter completed its Phase 3 clinical trial of HyQ, immunoglobulin with rHuPH20, at the end of 2010. Baxter has stated it plans to submit a BLA filing during the second half of 2011 and to launch the product in 2012. The worldwide market for immunoglobulin totals approximately $6 billion and Baxter commands a sizeable share of the market.

  • Fourth Quarter and Year End 2010 Financial ResultsThe net loss for the fourth quarter of 2010 was $16.9 million, or $0.17 per share, compared with a net loss for the fourth quarter of 2009 of $12.7 million, or $0.14 per share. The net loss for the year ended December 31, 2010 was $53.2 million, or $0.56 per share, compared to a net loss of $58.4 million, or $0.67 per share, for the year 2009.

  • Revenue for the fourth quarter of 2010 was $3.6 million, compared to $6.4 million for the
    '/>"/>

  • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
    2. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
    3. Halozyme Therapeutics Realigns Management
    4. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
    5. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
    6. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
    7. Halozyme Therapeutics Announces Public Offering of Common Stock
    8. Halozyme Provides HYLENEX® Product Reintroduction Update
    9. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
    10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
    11. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... Pharma Ltd. (the "Company") (NASDAQ: NTEC ), a ... on its proprietary Accordion Pill platform technology, today announced ... the United States of 5,025,000 of ... of $6.00 per ordinary share, before underwriting discounts and ... by the Company.  In addition, the Company has granted ...
    (Date:8/4/2015)... 2015 P&S Market Research ... trends, DRO analysis, market segmentation, market size and ... top competitor profiles in: Global Industry ... and Demand Forecast to 2020       ... full reports with detailed TOC on Global Drug ...
    (Date:8/4/2015)... KNOXVILLE, Tenn., Aug. 4, 2015 Second ... million; 30.1% over second quarter of 2014 , Net ... $28.9 million; $51.2 million after adjustments , Diluted net ... , Adjusted EBITDA increased 15.2% to $99.4 million ... increased to a range of 24.0% to 26.0%; Adjusted EBITDA ...
    Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30
    (Date:8/4/2015)... ... August 04, 2015 , ... How cool is it to check in ... geolocation? The new "Now" feature will soon allow you to do just that. , ... each other using the now feature. , Users will soon get to share what ...
    (Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River Casinos, the ... a 501(c) nonprofit organization. , According to the New Foundation AZ spokesperson , ... a package that includes a complimentary foursome for the tournament, as well as getting ...
    (Date:8/4/2015)... ... , ... assistPoint Partners, LLC is proud to announce ... programs. Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers ... application and workflow solution. This provides cancer center patient advocates, financial counselors and ...
    (Date:8/4/2015)... East Providence, RI (PRWEB) , ... August 04, 2015 , ... ... new satellite imaging center in the George Washington Medical Building on Wake Robin Road ... More importantly, the Wake Robin office will offer the most extensive out-patient x-ray hours ...
    (Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th ... a viable method for encouraging people to lose weight. Specifically the study compared control ... weight loss success, adding a financial incentive to the overall incentive of increased health. ...
    Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:assistPoint.com Web Site Launched 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2
    ... of Medicine (BUSM) and Public Health along with ... test scores not affected by intrauterine exposure to ... children who had no evidence of fetal alcohol ... math reasoning and spelling even after controlling for ...
    ... , FRIDAY, March 2 (HealthDay News) -- Approximately ... 50 and 75 who should be screened for colorectal ... for Gastrointestinal Endoscopy. As National Colorectal Cancer Awareness ... about the benefits of a colonoscopy exam to screen ...
    ... HealthDay Reporter , FRIDAY, March 2 (HealthDay News) -- ... demands of their own biology, women are more likely than ... see insomnia much more frequently in women, probably at least ... an assistant professor of neurology at the University of Texas ...
    ... matter. With this knowledge, University of Georgia researchers developed ... should be located. The results of their work could ... who dial 911 each year, according to the Federal ... critical time window [of 8 minutes], we can maximize ...
    ... of chains, which slowly break over time due to the ... squeezed, the pressure breaks chemical bonds and produces free radicals: ... are responsible for aging, DNA damage and cancer in the ... turned to squeezed polymers and free radicals in a search ...
    ... News) -- Researchers report they have developed a blood ... likely to experience the most severe symptoms of the disease. ... can suffer intense pain, internal organ damage and shortened ... to have the disease, which is caused by a genetic ...
    Cached Medicine News:Health News:Study finds intrauterine exposure to drugs does not affect academic achievement test scores 2Health News:Too Many Americans Skipping Colon Cancer Screening 2Health News:For Sleep Struggles, Women Urged to Alter Routines 2Health News:For Sleep Struggles, Women Urged to Alter Routines 3Health News:For Sleep Struggles, Women Urged to Alter Routines 4Health News:GIS siting of emergency vehicles improves response time 2Health News:Energy squeeze 2Health News:Energy squeeze 3Health News:Sickle Cell Blood Test Might Predict Severity of Disease 2
    ... Utilizing the most complex grinding ... accurate trial lens, are specifically ... quality and precision as the ... marco RT-300 refractor. Marco custom ...
    Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
    Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
    Minus cylinders only trial lens set....
    Medicine Products: